Age Related Hearing Loss Market

DelveInsight’s ‘Age-related Hearing Loss- Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Age-related Hearing Loss and the historical and forecasted Age-related Hearing Loss market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Age-related Hearing Loss market report provides an overview of Age-related Hearing Loss, its cause, diagnosis, treatment including detailed chapters on types of devices.


Additionally, this report covers the overview, various treatment practices, and Age-related Hearing Loss forecasted epidemiology from 2018 to 2026, segmented by the seven major markets.The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Age-related Hearing Loss Understanding

Age-related Hearing Loss Overview

Age-related hearing loss (AHL), also known as presbycusis, is an extremely complicated disease that is observed to be affecting tens of millions of people around the world. It is a progressive, irreversible and symmetrical bilateral neurosensory hearing loss resulting from the degeneration of the cochlea, wherein the sound-induced vibrations are illustrated by the sensory hair cells into the electrical signals within the cochlear neurons that further help in relaying information to the brain region.The condition is assumed to be one of the most prevalent chronic conditions that have affected the aged population, accounting for half of those over the age of 65 in the United States. AHL often leads people to withdraw from friends and becoming depressed and aloof.


According to World Health Organization (WHO), almost one-third of the people that are over 65 years are affected by disabling hearing loss. In 2025, it has been estimated that there will be almost 1.2 billion people over the age of 60 worldwide, with more than 500 million people who will suffer a prominent impairment due to presbycusis.

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan


Study Period: 2018–2026

List of Companies:

  • Advanced Bionics
  • Cochlear
  • MED-EL GmbH
  • Nurotron Biotechnology
  • Oticon Medical
  • Medtronic
  • Envoy Medical
  • Sonova
  • Audina Hearing Instruments
  • RION
  • Decibel Therapeutics
  • Frequency Therapeutics
  • Pipeline Therapeutics, Inc.

More companies in the report…

Age-related Hearing Loss- Competitive Analysis

This segment of the report provides a brief competitive analysis of Age-related Hearing Loss to help understand the competition in the market. It gives a comparative understanding of the products based on parameters such as type of regulatory approval.


Age-related Hearing Loss: Eligible Patient Population

This segment of the report provides an analysis of the eligible patient pool that incorporate Age-related Hearing Loss for their treatment, across 7MM during the study period (2018 and 2026).

Age-related Hearing Loss: Market Analysis

This segment illustrates the market of Age-related Hearing Loss across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a CAGR of XX%.


Age-related Hearing Loss: Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the Age-related Hearing Loss market.


Market Drivers:

  • An upsurge in the number of ongoing clinical trials
  • Rise in the prevalence of hearing loss patients
  • Advancements in technological and modern sequencing technologies


Market Barriers:

  • To date, existing pharmacologic therapies for genetic and acquired etiologies of deafness are severely limited
  • Various gene therapy complications
  • Product recalls or device issue

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Age-related Hearing Loss domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Age-related Hearing Loss market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of age-related hearing loss explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • Comprehensive insight has been provided into the epidemiology of the Age-related Hearing Loss and its treatment in the 7MM
  • Additionally, a complete account of both the current and emerging treatment for Age-related Hearing Loss is provided, along with the assessment of new therapies, which is likely to have an impact on the current market landscape.
  • A detailed review of Age-related Hearing Loss market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Age-related Hearing Loss market.

Report Highlights

  • The report covers descriptive overview of age-related hearing loss, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • The report provides an insight into the patient population eligible for age-related hearing loss in the 7MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Age-related Hearing Loss market.
  • The report also reviews the detailed global historical and forecasted age-related hearing loss market including assessing the outreach in 7MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Age-related Hearing Loss market.

Age-related Hearing Loss Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage 
  • Competitive Landscape
  • Patient pool
  • Market Size

Age-related Hearing Loss Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views
  • PEST Analysis

Key Questions

Market Insights:

  • What was the age-related hearing loss market share (%) distribution in 2018 and how it will look like in 2026?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest age-related hearing loss market size during the forecast period (2018–2026)?
  • At what CAGR, the age-related hearing loss market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the age-related hearing loss market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the age-related hearing loss market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the age-related hearing loss market?
  • What is the age-related hearing loss available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing age-related hearing loss?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Age-related Hearing Loss?
  • What are the key designations that have been granted for the current age-related hearing loss?
  • What are the 7MM historical and forecasted market of age-related hearing loss?

Frequently Asked Questions 

What is Age-related Hearing Loss?

Age-related hearing loss (AHL), also known as presbycusis, is an extremely complicated disease that is observed to be affecting tens of millions of people around the world.


How is Age-related Hearing Loss Market Segmented?

The ‘Age-related Hearing Loss is segmented on the basis of By Product Type and by End User.


Who are the leading companies in Age-related Hearing Loss Market Landscape?

The leading companies that are working in the ‘Age-related Hearing Loss Market are Advanced Bionics, Cochlear, MED-EL GmbH, Nurotron Biotechnology, Oticon Medical, Medtronic Envoy Medical, Sonova, Audina Hearing Instruments, RION, Decibel Therapeutics, Frequency Therapeutics Pipeline Therapeutics, Inc. and many others.


What are the Age-related Hearing Loss Market Drivers?

The market driver is the upsurge in the number of ongoing clinical trials, rise in the prevalence of hearing loss patients and advancements in technological and modern sequencing technologies.


What are the Age-related Hearing Loss Market Barriers?

The market barrier is the date, existing pharmacologic therapies for genetic and acquired etiologies of deafness are severely limited, various gene therapy complications and Product recalls or device issues.


What are the key strengths of the Age-related Hearing Loss Market Report?

Key strengths of Age-related Hearing Loss Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of COVID-19 on the Age-related Hearing Loss Market?

The Age-related Hearing Loss Market had observed a positive shift in market revenues due to the COVID 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1 Key insights

2 Report introduction

3 Executive summary of age-related hearing loss

4 Age-related hearing loss: disease background and overview

4.1 Introduction

4.2 Disease background

4.3 Pathology

4.4 Pathophysiology

4.5 Signs and symptoms

4.6 Diagnosis

4.7 Treatment and management

5 Regulatory and reimbursement of age-related hearing loss devices

5.1 Regulatory approval for the devices

5.1.1 United States Regulation of Devices

5.1.2 European Regulation of Devices

5.1.3 Japan Regulation of Devices

5.2 Reimbursement scenario for age-related hearing loss devices

5.2.1 United states

5.2.2 Europe

5.2.3 Japan

6 Age-related hearing loss: marketed products

6.1 Cochlear implant

6.1.1 Regulatory milestones

6.1.2 Product Profiles of Major Players

6.2 Bone Conduction Hearing Implants (BAHA)

6.2.1 Overview

6.2.2 Regulatory Milestones

6.2.3 Product Profiles of Major Players

6.3 Middle Ear Implant

6.3.1 Overview

6.3.2 Product Profiles of Major Players

6.4 Hearing Aids

6.4.1 Overview

6.4.2 List of Key Players and their Hearing Aid Products

7 Age-Related Hearing Loss: Emerging Pharmacotherapies

7.1 DB-OTO: DECIBEL THERAPEUTICS

7.1.1 Drug Description

7.1.2 Clinical Development

7.1.3 Product Profile

7.2 FX-322: FREQUENCY THERAPEUTICS

7.2.1 Drug Description

7.2.2 Clinical Development

7.2.3 Clinical Trials Information

7.2.4 Product Profile

7.3 PIPE-505: PIPELINE THERAPEUTICS, INC.

7.3.1 Drug Description

7.3.2 Clinical Development

7.3.3 Clinical Trials Information

7.3.4 Product Profile

8 Age-Related Hearing Loss: Emerging Medical Devices

8.1 ACCLAIM® COCHLEAR IMPLANT

9 Patient Journey

10 Case Reports

11 Organizations Contributing Towards Deafness

12 KOL Views

13 Assumptions And Rationale – Eligible Patient Population And Market Analysis For Age-Related Hearing Loss

13.1 Epidemiology Assumptions

13.2 Market Outlook

14 Age-Related Hearing Loss: 7 Major Market Epidemiology

14.1 Key Findings

14.2 7MM Total Diagnosed Prevalent Patient Population Of Age-Related Hearing Loss

14.3 The United States

14.3.1 Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In The United States

14.3.2 Age-Specific Prevalent Population Of Age-Related Hearing Loss In The United States

14.3.3 Gender-Specific Population Of Age-Related Hearing Loss In The United States

14.3.4 Severity-Specific Patient Pool Of Age-Related Hearing Loss In The United States

14.3.5 Treatable Patient Pool Of Age-Related Hearing Loss In The United States

14.4 EU5

14.4.1 Germany

14.4.2 France

14.4.3 Spain

14.4.4 Italy

14.4.5 UK

14.5 Japan

14.5.1 Total diagnosed Prevalent Cases of Age-related Hearing Loss in Japan

14.5.2 Age-specific prevalent population of Age-related Hearing Loss in Japan

14.5.3 Gender-specific population of Age-related Hearing Loss in Japan

14.5.4 Severity-specific patient pool of Age-related Hearing Loss in Japan

14.5.5 Treatable patient pool of Age-related Hearing Loss in Japan

15 Age-Related Hearing Loss: 7 Major Market Analysis

15.1 Key Findings

15.2 Market Size Of Age-Related Hearing Loss In 7MM

15.3 United States

15.3.1 Market Size Of Age-Related Hearing Loss In The United States

15.4 Germany

15.4.1 Market Size Of Age-Related Hearing Loss In Germany

15.5 France

15.5.1 Market Size Of Age-Related Hearing Loss In France

15.6 Spain

15.6.1 Market Size Of Age-Related Hearing Loss In Spain

15.7 Italy

15.7.1 Market Size Of Age-Related Hearing Loss In Italy

15.8 United Kingdom

15.8.1 Market Size Of Age-Related Hearing Loss In The United Kingdom

15.9 Japan

15.9.1 Market Size Of Age-Related Hearing Loss In Japan

16 Market Drivers

17 Market Barriers

18 SWOT Analysis

19 Unmet Needs

20 Appendix

20.1 Bibliography

20.2 Report Methodology

21 Delveinsight Capabilities

22 Disclaimer

23 About Delveinsight

List of Table

Table 1: Severity Of Hearing Loss In Decibels (Db)

Table 2: Treatment Of Hearing Loss

Table 3: Assessment Based On Stage

Table 4: List Of Hearing Aids*

Table 5: Fx-322, Clinical Trial Description,2020

Table 6: Pipe-505, Clinical Trial Description, 2020

Table 7: Organizations Contributing Toward The Fight Against Deafness

Table 8: Organizations Contributing Toward The Fight Against Age Related Hearing Loss

Table 9: Diagnosed Prevalent Patient Population Of Age-Related Hearing Loss In 7mm (2018–2026)

Table 10: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In The United States (2018–2026)

Table 11: Age-Specific Prevalent Population Of Age-Related Hearing Loss In The United States (2018–2026)

Table 12: Gender-Specific Population Of Age-Related Hearing Loss In The United States (2018–2026)

Table 13: Severity-Specific Patient Pool Of Age-Related Hearing Loss In The United States (2018–2026)

Table 14: Treatable Patient Pool Of Age-Related Hearing Loss In The United States (2018–2026)

Table 15: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Germany (2018–2026)

Table 16: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Germany (2018–2026)

Table 17: Gender-Specific Population Of Age-Related Hearing Loss In Germany (2018–2026)

Table 18: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Germany (2018–2026)

Table 19: Treatable Patient Pool Of Age-Related Hearing Loss In Germany (2018–2026)

Table 20: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In France (2018–2026)

Table 21: Age-Specific Prevalent Population Of Age-Related Hearing Loss In France (2018–2026)

Table 22: Gender-Specific Population Of Age-Related Hearing Loss In France (2018–2026)

Table 23: Severity-Specific Patient Pool Of Age-Related Hearing Loss In France (2018–2026)

Table 24: Treatable Patient Pool Of Age-Related Hearing Loss In France (2018–2026)

Table 25: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Spain (2018–2026)

Table 26: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Spain (2018–2026)

Table 27: Gender-Specific Population Of Age-Related Hearing Loss In Spain (2018–2026)

Table 28: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Spain (2018–2026)

Table 29: Treatable Patient Pool Of Age-Related Hearing Loss In Spain (2018–2026)

Table 30: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Italy (2018–2026)

Table 31: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Italy (2018–2026)

Table 32: Gender-Specific Population Of Age-Related Hearing Loss In Italy (2018–2026)

Table 33: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Italy (2018–2026)

Table 34: Treatable Patient Pool Of Age-Related Hearing Loss In Italy (2018–2026)

Table 35: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Uk (2018–2026)

Table 36: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Uk (2018–2026)

Table 37: Gender-Specific Population Of Age-Related Hearing Loss In Uk (2018–2026)

Table 38: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Uk (2018–2026)

Table 39: Treatable Patient Pool Of Age-Related Hearing Loss In Uk (2018–2026)

Table 40: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Japan(2018–2026)

Table 41: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Japan (2018–2026)

Table 42: Gender-Specific Population Of Age-Related Hearing Loss In Japan (2018–2026)

Table 43: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Japan (2018–2026)

Table 44: Treatable Patient Pool Of Age-Related Hearing Loss In Japan (2018–2026)

Table 45: Market Size Of Age-Related Hearing Loss In 7mm, Usd Million (2018–2026)

Table 46: Market Size Of Age-Related Hearing Loss In The United States, Usd Million (2018–2026)

Table 47: Market Size Of Age-Related Hearing Loss In Germany, Usd Million (2018–2026)

Table 48: Market Size Of Age-Related Hearing Loss In France, Usd Million (2018–2026)

Table 49: Market Size Of Age-Related Hearing Loss In Spain, Usd Million (2018–2026)

Table 50: Market Size Of Age-Related Hearing Loss In Italy, Usd Million (2018–2026)

Table 51: Market Size Of Age-Related Hearing Loss In Uk, Usd Million (2018–2026)

Table 52: Market Size Of Age-Related Hearing Loss In Japan, Usd Million (2018–2026)

List of Figures

Figure 1: Types Of Hearing Loss

Figure 2: Pathophysiology Of Presbycusis

Figure 3: Class Iii Device Approval Processes In Japan

Figure 4: Ear With Cochlear Implants

Figure 5: Hires Ultra Cochlear Implant

Figure 6: Hires Ultra 3d Cochlear Implant

Figure 7: Hires 90k Implant Family

Figure 8: Nucleus Cochlear Implant System

Figure 9: Synchrony 2 Cochlear Implant

Figure 10: Nurotron Cochlear Implant System

Figure 11: Bonebridge

Figure 12: Osia 2 System

Figure 13: Osia 2 System

Figure 14: Alpha 2 Mpo Eplus™ System

Figure 15: Vibrant Soundbridge

Figure 16: Vibrant Soundbridge

Figure 17: Styles Of Hearing Aids Figure 18: Acclaim® Cochlear Implant

Figure 19: Diagnosed Prevalent Patient Population Of Age-Related Hearing Loss In 7mm (2018–2026)

Figure 20: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In The United States (2018–2026)

Figure 21: Age-Specific Prevalent Population Of Age-Related Hearing Loss In The United States (2018–2026)

Figure 22: Gender-Specific Population Of Age-Related Hearing Loss In The United States (2018–2026)

Figure 23: Severity-Specific Patient Pool Of Age-Related Hearing Loss In The United States (2018–2026)

Figure 24: Treatable Patient Pool Of Age-Related Hearing Loss In The United States (2018–2026)

Figure 25: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Germany (2018–2026)

Figure 26: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Germany (2018–2026)

Figure 27: Gender-Specific Population Of Age-Related Hearing Loss In Germany (2018–2026)

Figure 28: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Germany (2018–2026)

Figure 29: Treatable Patient Pool Of Age-Related Hearing Loss In Germany (2018–2026)

Figure 30: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In France (2018–2026)

Figure 31: Age-Specific Prevalent Population Of Age-Related Hearing Loss In France (2018–2026)

Figure 32: Gender-Specific Population Of Age-Related Hearing Loss In France (2018–2026)

Figure 33: Severity-Specific Patient Pool Of Age-Related Hearing Loss In France (2018–2026)

Figure 34: Treatable Patient Pool Of Age-Related Hearing Loss In France (2018–2026)

Figure 35: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Spain (2018–2026)

Figure 36: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Spain (2018–2026)

Figure 37: Gender-Specific Population Of Age-Related Hearing Loss In Spain (2018–2026)

Figure 38: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Spain (2018–2026)

Figure 39: Treatable Patient Pool Of Age-Related Hearing Loss In Spain (2018–2026)

Figure 40: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Italy (2018–2026)

Figure 41: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Italy (2018–2026)

Figure 42: Gender-Specific Population Of Age-Related Hearing Loss In Italy (2018–2026)

Figure 43: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Italy (2018–2026)

Figure 44: Treatable Patient Pool Of Age-Related Hearing Loss In Italy (2018–2026)

Figure 45: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Uk (2018–2026)

Figure 46: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Uk (2018–2026)

Figure 47: Gender-Specific Population Of Age-Related Hearing Loss In Uk (2018–2026)

Figure 48: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Uk (2018–2026)

Figure 49: Treatable Patient Pool Of Age-Related Hearing Loss In Uk (2018–2026)

Figure 50: Total Diagnosed Prevalent Cases Of Age-Related Hearing Loss In Japan(2018–2026)

Figure 51: Age-Specific Prevalent Population Of Age-Related Hearing Loss In Japan (2018–2026)

Figure 52: Gender-Specific Population Of Age-Related Hearing Loss In Japan (2018–2026)

Figure 53: Severity-Specific Patient Pool Of Age-Related Hearing Loss In Japan (2018–2026)

Figure 54: Treatable Patient Pool Of Age-Related Hearing Loss In Japan (2018–2026)

Figure 55: 7 Major Market Size Of Age-Related Hearing Loss In Usd Million (2018–2026)

Figure 56: Market Size Of Age-Related Hearing Loss In The United States, Usd Million (2018–2026)

Figure 57: Market Size Of Age-Related Hearing Loss In Germany, Usd Million (2018–2026)

Figure 58: Market Size Of Age-Related Hearing Loss In France, Usd Million (2018–2026)

Figure 59: Market Size Of Age-Related Hearing Loss In Spain, Usd Million (2018–2026)

Figure 60: Market Size Of Age-Related Hearing Loss In Italy, Usd Million (2018–2026)

Figure 61: Market Size Of Age-Related Hearing Loss In Uk, Usd Million (2018–2026)

Figure 62: Market Size Of Age-Related Hearing Loss In Japan, Usd Million (2018–2026)

• Advanced Bionics

• Cochlear

• MED-EL GmbH

• Nurotron Biotechnology

• Oticon Medical

• Medtronic

• Envoy Medical

• Sonova

• Audina Hearing Instruments

• RION

• Decibel Therapeutics

• Frequency Therapeutics

• Pipeline Therapeutics, Inc.

  • Tags:
  • Age-related Hearing Loss
  • Age-related Hearing Loss Mechanism
  • Age-related Hearing Loss Companies
  • Age-related Hearing Loss Medical...
  • Age-related Hearing Loss Market
  • Age-related Hearing Loss Industry
  • Age-related Hearing Loss Market Si...
  • Age-related Hearing Loss Market Sh...
  • Age-related Hearing Loss Companies
  • Age-related Hearing Loss devices

Forward to Friend

Need A Quote